Stockholders approve charter amendment cutting authorized shares from 500M to 26M

Future Health ESG Corp.

Amendment reduces authorized common shares from 500,000,000 to 26,000,000.
Vote: 4,802,623 for, 0 against, 0 abstain at special meeting on Jan 31, 2023.
Charter amendment filed with Delaware Secretary of State on same date.
Company trades units, common, warrants on Nasdaq under FHLTU, FHLT, FHLTW.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Future Health ESG Corp.: Approval and filing of Charter Amendment to decrease authorized common shares from 500,000,000 to 26,000,000 (effective 2023-01-31).

Change: charter amendment
Effective: 2023-01-31

Exact text from the filing

At the Meeting, the Company’s stockholders approved an amendment (the “ Charter Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Future Health ESG Corp. shareholders approved Charter Amendment to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000.

Proposal: charter amendment
Outcome: passed

Exact text from the filing

At the Meeting, the Company’s stockholders approved the Charter Amendment to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000 (the “ Charter Amendment Proposal ”). The final voting results for the Charter Amendment Proposal were as follows: For Against Abstain 4,802,623 0 0

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001104659-23-008801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.